Effect of alpha 2b interferon on inducement of mIL-2R and treatment of HCV in PBMC from patients with chronic viral hepatitis C

Table 3 The level of mIL-2R before and after treatment of in-terferon (n, x^-± s, %)

Group	n	mIL-2R (in silence)		mIL-2R (inducement)
		Before treatment	After treatment	Before treatment	After treatment
Interferon treatment	26	2.63 ± 0.70	3.44 ± 0.77bcd	30.34 ± 3.55	33.62 ± 3.95cd
Routin treatment	22	2.43 ± 0.78	2.95 ± 0.72ad	30.07 ± 3.87	30.04 ± 3.73d
Normal control	20	4.54 ± 1.48		37.42 ± 4.10

^aP < 0.05,

^bP < 0.01 vs before and after treatment,

^cP < 0.05,

^dP < 0.01 vs interferon treatment.